Skip to content

6-KAccepted Sep 24, 8:27 AM ET

NERVGEN PHARMA CORP. 6-K

NGENNERVGEN PHARMA CORP.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

8:27 AM

Sep 24, 2026

Filed

Sep 24, 2026

Documents

8

Size

46.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.